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assigned point values based on impact on survival: rupture
(10 points), anticoagulation usage (4 points), renal failure
(1 point), and female gender (1 point). Patients with the
lowest risk of mortality were those with a score ranging
from e4 to 1 (1.4% risk of mortality), followed by those
with a range of 2 to 6 (13.3% mortality risk), 7 to 12
(33% mortality risk), and ﬁnally 13 to 16 (45.5%) risk of
death. A risk register was created with these data.
Conclusions: This study demonstrates that not all pa-
tients with AAA between 5 and 5.5 cm are candidates for
surgery. Higher-risk patients may beneﬁt from endovascu-
lar aneurysm repair (EVAR), and those patients with
smaller aneurysm sizes and few risk factors may beneﬁt
from observation. Women, patients with renal failure, and
anticoagulated patients all have a greater risk of in-hospital
mortality. Patients who undergo EVAR have signiﬁcantly
lower in-hospital mortality, especially those patients who
have a ruptured AAA.
Author Disclosures: S. S. Desai: Nothing to disclose; A.
Dua: Nothing to disclose; S. Kuy: Nothing to disclose; G.
R. Upchurch: Nothing to disclose.PS134.
Does Increased Cost in the Treatment of Superﬁcial
Femoral Artery Disease Lead to Better Outcomes?
Karen L. Walker, Jesse A. Columbo, Eva M. Rzucidlo,
Samuel T. Simone, Philip P. Goodney, Richard J. Powell.
Vascular Surgery, Dartmouth Hitchcock, Lebanon, NH
Objectives: Patients considered for endovascular treat-
ment of superﬁcial femoral artery (SFA) disease present
with a wide array of lesion complexity and treatment op-
tions. This study aims to examine the cost drivers of SFA
stent treatment and their impact on outcome.
Methods: We retrospectively collected clinical and
ﬁnancial data on patients undergoing SFA stenting to eval-
uate the relationship between direct procedural cost and 1-
year patency. Adjuncts to SFA stenting were deﬁned as
stent grafts, atherectomy, re-entry, and embolic protection
devices.
Results: We studied 95 patients who underwent SFA
stenting from January 2010 to February 2012. Patients
were a mean age of 71 years, 62% were male, 41% were
diabetic, 46% had critical limb ischemia (CLI), and 24%
had a TASC C or D lesion. Primary patency at 1 year
was better in patients with claudication than those with
CLI (91% vs 74%, P ¼ .06). Whereas the rate of adjunct
use was similar in patients with claudication and CLI
(12%), more adjuncts were used in patients with TASC
C and D lesions (22% C and D, 8% A and B, P ¼ .09).
Mean direct costs for SFA stenting without adjunct use
was $2838 (95% conﬁdence interval, $2586-$3089),
whereas adjunct use increased mean costs to $7318
(95% conﬁdence interval, $4817-$9820; P < .01). Multi-
variate regression showed that TASC C/D classiﬁcation
and adjunct use were associated with the highest tertile
of costs, OR 13.5 and 36.8 respectively (P < .01). There
was no association between cost and primary patency
(Fig).
Conclusions: Adjunct devices are often necessary to
achieve technical success for treatment of TASC C and DSFA lesions. Their use is associated with increased cost,
yet has limited impact on midterm patency.
Author Disclosures: J. A. Columbo: Nothing to disclose;
P. P. Goodney: Nothing to disclose; R. J. Powell:
Nothing to disclose; E. M. Rzucidlo: Nothing to disclose;
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Results of the Retrocarotid Dissection Technique in
the Treatment of Carotid Body Tumors
Carlos A. Hinojosa1, Laura J. Ortiz-López1, Vicente
Orozco-Sevilla2, Ana E. Nuñez-Salgado1. 1Section of
Vascular Surgery and Endovascular Therapy, National
Institute of Medical Sciences and Nutrition “Salvador
Zubirán,” Mexico City, Mexico; 2Mount Sinai School of
Medicine, Department of Cardiothoracic Surgery, New
York, NY
Objectives: To determine if the retrocarotid dissection
technique has advantages over the standard caudal-cranial
approach in regards of bleeding, surgical time, vascular or
nervous injury, and hospital stay in patients with carotid
body tumors (CBT).
Methods: A prospective cohort of patients who under-
went surgical treatment with retrocarotid dissection tech-
nique (RC) at our institution between July 2007 and
January 2013 was reviewed. This cohort was compared
with a historical group of patients treated with standard
approach (SA; caudal-cranial dissection) between 1995 and
2007. Intraoperative parameters and operative outcomes
were compared using the Fisher exact test for categoric vari-
ables, and Mann-Whitney U test for continuous variables. A
P < .05 was considered as statistically signiﬁcant.
Results: A total of 68 resections (41 SA, 27 RC) in 68
patients (62 female and 8 male; mean age, 54.3 years) were
performed. Comparative analysis identiﬁed mean blood
loss of 476 mL (standard deviation [SD] 378 mL) in the
RC group and 694.39 mL (SD, 682 mL) for the SA cohort
(P <. 31). The mean surgical time was 172 minutes (SD,
60 minutes) for the RC group and 260 minutes (SD,
97.7 minutes) for the SA group (P <. 001). The hospital
stay was signiﬁcantly shorter for the RC group with an
Table. Odds ratio for readmission based on patient
speciﬁc characteristics among individuals undergoing
open and endovascular procedures
OR 95% CI P
Endovascular procedures
Age 0.98 0.96-1.00 .069
Female Sex 1.48 0.89-2.45 .133
Length of Stay 1.01 0.96-1.05 .822
Smoking (yes) 0.73 0.41-1.32 .300
Dialysis (yes) 4.02 2.08-7.77 <.001
Hypertension (yes) 2.13 0.92-4.94 .077
Diabetes (yes) 0.78 0.44-1.38 .391
BM 0.97 0.93-1.01 .156
COPD (yes) 1.66 0.84-3.26 .144
Elective Surgery (yes) 0.30 0.15-0.61 .001
Open procedures
Age 1.01 0.99-1.03 .379
Female Sex 1.34 0.87-2.08 .182
Length of Stay 1.00 0.98-1.02 .945
Smoking (yes) 0.99 0.60-1.63 .954
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for the SA cohort (P < .0001). Signiﬁcant differences in
intraoperative vascular lesions were not identiﬁed. Cranial
nerve damage was observed in 17 patients: six transient
nerve palsies in the RC cohort, and 11 in the SA group.
There were three patients with postoperative transient
ischemic attacks in the SA cohort, with none observed in
the RC group. This translates into a rate of 21% of postop-
erative complications for the RC cohort and 34% in the SA
group (P <. 08)
Conclusions: The retrocarotid dissection technique is
a safe, viable option for the treatment of CBT. It is associ-
ated with a signiﬁcant decrease in surgical time and hospital
stay.
Author Disclosures: C. A. Hinojosa: Nothing to
disclose; A. E. Nuñez-Salgado: Nothing to disclose; V.
Orozco-Sevilla: Nothing to disclose; L. J. Ortiz-López:
Nothing to disclose.Dialysis (yes) 2.60 1.07-6.31 .035
Hypertension (yes) 1.40 0.73-2.67 .311
Diabetes (yes) 1.53 0.95-2.47 .079
BMI 0.98 0.95-1.02 .390
COPD (yes) 1.20 0.65-2.25 .560
Elective Surgery (yes) 0.64 0.39-1.05 .079PS138.
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Objectives: Patients undergoing vascular surgery have
a high rate of unplanned 30-day readmission. The costs
associated with readmission have not been described. The
objective of this study is to determine the excess cost due
to 30-day unplanned readmission for patients undergoing
vascular surgery.
Methods: The American College of Surgeons Na-
tional Surgical Quality Improvement Program (ACS-
NSQIP) database was used to identify patients undergoing
vascular surgery at a single institution from January 2011
through June 2012. Costs for each patient’s index hospital-
ization, as well as all unplanned 30-day readmissions were
obtained using SAP BusinessObjects. Logistic regression
analyses were performed to determine associations between
patient characteristics and readmission, and t-tests were
performed for cost comparison.
Results: During the study period, 689 endovascular
and 648 open procedures were performed. The mean cost
of care for patients who required readmission after endovas-
cular procedures was $48,131 compared with $18,803 for
those not requiring readmission (P < .0001). The mean
cost of care for patients who required readmission after
open surgery was $49,605 compared with $27,820 for
those not requiring readmission (P < .0001). Refer to the
Table for results of logistic regression.
Conclusions: Here we have shown that 30-day un-
planned readmission after vascular surgery is associated
with a signiﬁcant increase in cost. The mean cost of care
for endovascular patients requiring readmission is >2.5-
times greater than those who do not. Similarly, the mean
cost of care for patients readmitted following open proce-
dures is >1.75-times greater than those who are not.Author Disclosures: T. Easterday: Nothing to disclose;
A. S. Gracon: Nothing to disclose; G. Lemmon: Nothing
to disclose; R. Motaganahalli: Nothing to disclose; J.
Slaven: Nothing to disclose; D. J. Weber: Nothing to
disclose.PS140.
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Objectives: We analyzed trends in endovascular aneu-
rysm repair (EVAR) length of stay (LOS) at a tertiary aca-
demic institution over the last decade.
Methods: Infrarenal EVARs from 2001 to 2013
were divided into three groups: 2001 to 2004: per-
formed as part of clinical trials; 2005 to 2008: multiple
devices were Food and Drug Administration-approved;
2009 to 2013: complex EVARs referred to academic
institutions. Trends in LOS and correlation with
severity of illness (SOI) based on All Patient Reﬁned
Diagnosis Related Groups (APR-DRG), and admis-
sion/disposition status were analyzed. LOS index was
compared with University Health Consortium (UHC)
Hospitals over the past 3 years.
Results: A total of 1265 EVARs were performed:
325 in group 1, 547 in group 2, and 393 in group 3.
Average LOS was 5.5 vs 4.9 vs 6 days (P < .01). While
moderate SOI was constant over time (P ¼ .66), preva-
lence of major/extreme SOI was greater in group 1,
reduced in group 2, and again increased in group 3 (P
< .01; Fig). The complication rate paralleled this pattern
(15.2% vs 8.6% vs 10.4%; P ¼ .02). The percentage of
patients discharged to a nursing home was 5.7% vs
8.2% vs 11.5% (P ¼ .03). Cases performed emergently
